Systemic Sclerosis-associated Interstitial Lung Disease (SSc-ILD) research hub

Exploratory, non-randomized, 3-group, microdosing clinical trial to investigate Gallium-68 (68Ga) labeled Platelet-Derived Growth Factor Beta (PDGFRß) targeting Positron Emission Tomography (PET) tracer (68Ga-ATH001) binding in the lungs in healthy participants versus participants with Systemic Sclerosis-associated Interstitial Lung Disease (SSc-ILD)

This study is looking at a new way to scan the lungs using a special dye. It wants to see if this scan can help understand lung problems in people with a condition called Systemic Sclerosis-associated Interstitial Lung Disease (SSc-ILD), compared to healthy people.